Journal of pharmacological sciences最新文献

{"title":"Amitriptyline and duloxetine attenuate activities of superficial dorsal horn neurons in a rat reserpine-induced fibromyalgia model","authors":"Daisuke Uta ,&nbsp;Katsuyuki Tsuboshima ,&nbsp;Kazue Mizumura ,&nbsp;Hisao Nishijo ,&nbsp;Toru Taguchi","doi":"10.1016/j.jphs.2024.08.006","DOIUrl":"10.1016/j.jphs.2024.08.006","url":null,"abstract":"<div><p>Fibromyalgia (FM) is an intractable disease with a chief complaint of chronic widespread pain. Amitriptyline (AMI) and duloxetine (DLX), which are antidepressant drugs, have been reported to ameliorate pain in patients with FM and pain-related behaviors in several rodent models of FM. However, the mechanisms of action of AMI and DLX are not yet fully understood. Here, we examined the effects of these drugs on the responsiveness of superficial dorsal horn (SDH) neurons in the spinal cord, using a rat FM model developed by injecting a biogenic amine depleter (reserpine). Extracellular recordings of SDH neurons <em>in vivo</em> demonstrated that bath application of AMI and DLX at concentrations of 0.1–1.0 mM on the dorsal surface of the spinal cord markedly suppressed spontaneous discharge and von Frey filament-evoked mechanical firing in SDH neurons. The suppression induced by the drugs was noted in a concentration-dependent manner and the suppressive effects resolved after washing the spinal cord surface. These results show that SDH neurons are the site of action for AMI and DLX in a rat reserpine-induced FM model. Spinal mechanisms may underlie the therapeutic effects of these drugs in patients with FM.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 3","pages":"Pages 180-187"},"PeriodicalIF":3.0,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000628/pdfft?md5=9e053b739e9dddd2bd8d1a990fd5cd41&pid=1-s2.0-S1347861324000628-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142096895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In vivo cardiovascular profile of ryanodine receptor 2 inhibitor M201-A: Utility as an anti-atrial fibrillatory drug for patients suffering from heart failure with preserved ejection fraction","authors":"Ryuichi Kambayashi ,&nbsp;Ai Goto ,&nbsp;Makoto Shinozaki ,&nbsp;Hiroko Izumi-Nakaseko ,&nbsp;Yoshinori Takei ,&nbsp;Kunio Iwata ,&nbsp;Noboru Kaneko ,&nbsp;Atsushi Sugiyama","doi":"10.1016/j.jphs.2024.08.004","DOIUrl":"10.1016/j.jphs.2024.08.004","url":null,"abstract":"<div><p>Atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF) often coexist; however, clinically available anti-AF drugs can exacerbate symptoms of HFpEF. M201-A suppressed ryanodine receptor-mediated diastolic Ca²⁺ leakage, possibly inhibiting common pathological processes toward AF and HFpEF. To bridge the basic information to clinical practice, we assessed its cardiohemodynamic, anti-AF and ventricular proarrhythmic profile using halothane-anesthetized dogs (n = 4). M201-A hydrochloride in doses of 0.03, 0.3 and 3 mg/kg/10 min was intravenously administered, providing peak plasma concentrations of 0.09, 0.81 and 5.70 μg/mL, respectively. The high dose of M201-A showed various cardiovascular actions. Namely, M201-A increased mean blood pressure and tended to enhance isovolumetric ventricular relaxation without suppressing ventricular contraction or decreasing cardiac output. M201-A enhanced atrioventricular conduction, but hardy affected intra-atrial/ventricular conduction. Importantly, M201-A prolonged effective refractory period more potently in the atrium than in the ventricle, indicating that it may become an atrial-selective antiarrhythmic drug. Meanwhile, M201-A prolonged QT interval/QTcV, and showed reverse frequency-dependent delay of ventricular repolarization. M201-A prolonged J-T_peakc without prolonging T_peak-T_end or terminal repolarization period, indicating the risk of causing torsade de pointes is negligible. Thus, M201-A is expected to become a hopeful therapeutic strategy for patients having pathology of both AF and HFpEF.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 3","pages":"Pages 171-179"},"PeriodicalIF":3.0,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000604/pdfft?md5=3db6b114f7405a63b252c17bce83b376&pid=1-s2.0-S1347861324000604-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142096847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Oxymatrine alleviates NSAID-associated small bowel mucosal injury by regulating MIP-1/CCR1 signalling and gut microbiota","authors":"Ming Chen ,&nbsp;Haixia Zhou ,&nbsp;Jie Shen ,&nbsp;Miaomiao Wei ,&nbsp;Zhaoyu Chen ,&nbsp;Xiaoyu Chen ,&nbsp;Huining Fan ,&nbsp;Jing Zhang ,&nbsp;Jinshui Zhu","doi":"10.1016/j.jphs.2024.08.003","DOIUrl":"10.1016/j.jphs.2024.08.003","url":null,"abstract":"<div><p>Oxymatrine (OMT) as a quinazine alkaloid extracted from matrine has been shown to exhibit anti-inflammatory and anti-tumour effects. However, the protective mechanism of OMT on NSAID-associated small bowel mucosal injury remains unreported. We found that OMT could improve the clinical symptoms and pathological inflammation scoring, reduce the secretion of proinflammatory cytokines IL-1β, IL-6 and TNF-α and cell apoptosis, promote cell proliferation and protect intestinal mucosal barrier as compared with the Diclofenac Sodium (DS) group. Further RNA-seq and KEGG analysis uncovered that the differentially expressed genes between DS and control groups were mainly enriched in immune regulation, of which MIP-1γ and its receptor CCR1 expression were validated to be repressed by OMTH. MAPK/NF-κB as the MIP-1 upstream signalling was also inactivated by OMT treatment. In this study, OMT regulated gut microbiota. Venn diagrams visualized and identified 1163 shared OTUs between DS group and OMTH group. The results showed that the α diversity index in the DS group was lower than that in the OMTH group, indicating that the complexity of the flora was reduced in the intestinal inflammatory state. β diversity mainly includes Principal Component Analysis (PCA) and Principal Co-ordinates Analysis (PCoA). The differences between groups can be observed through PCA. The more similar the composition of the flora, the closer the samples are. We found that the difference was smaller in the DS group than in the OMTH group. The results of PcoA showed that the sample similarity between OMTH groups was the highest. Moreover, gut microbiota analysis unveiled that the abundances of <em>Ruminococcus 1</em>, <em>Oscillibacter</em> and <em>Prevotellaceae</em> at the genus level as well as <em>Lactobacillus</em> SP-L-Yj at the species level were increased in OMTH group as compared with the DS group but the abundance of <em>Allobaculum</em>, <em>Ruminococceos-UCG-005</em>, <em>Ruminococceos-NK4A214</em> and <em>Clostridium</em> associated with DS-induced small bowel mucosal injury could be decreased by OMTH. MIP-1α and CCR1 were upregulated in human small bowel injury samples as compared with the normal ileal mucosa tissues. In conclusion, our findings demonstrated that OMT could alleviate NSAID-associated small bowel mucosal injury by inhibiting MIP-1γ/CCR1 signalling and regulating gut microbiota.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 3","pages":"Pages 149-160"},"PeriodicalIF":3.0,"publicationDate":"2024-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000598/pdfft?md5=22d206d463d278866864a0310e23b1a7&pid=1-s2.0-S1347861324000598-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142002159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of D-Allose on experimental cardiac hypertrophy","authors":"Steeve Akumwami ,&nbsp;Asadur Rahman ,&nbsp;Masafumi Funamoto ,&nbsp;Akram Hossain ,&nbsp;Asahiro Morishita ,&nbsp;Yasumasa Ikeda ,&nbsp;Hiroaki Kitamura ,&nbsp;Kento Kitada ,&nbsp;Takahisa Noma ,&nbsp;Yuichi Ogino ,&nbsp;Akira Nishiyama","doi":"10.1016/j.jphs.2024.08.002","DOIUrl":"10.1016/j.jphs.2024.08.002","url":null,"abstract":"<div><p>The hallmark of pathological cardiac hypertrophy is the decline in myocardial contractility caused by an energy deficit resulting from metabolic abnormalities, particularly those related to glucose metabolism. Here, we aim to explore whether D-Allose, a rare sugar that utilizes the same transporters as glucose, may restore metabolic equilibrium and reverse cardiac hypertrophy. Isolated neonatal rat cardiomyocytes were stimulated with phenylephrine and treated with D-Allose simultaneously for 48 h. D-Allose treatment resulted in a pronounced reduction in cardiomyocyte size and cardiac remodelling markers accompanied with a dramatic reduction in the level of intracellular glucose in phenylephrine-stimulated cells. The metabolic flux analysis provided further insights revealing that D-Allose exerted a remarkable inhibition of glycolysis as well as glycolytic capacity. Furthermore, in mice subjected to a 14-day continuous infusion of isoproterenol (ISO) to induce cardiac hypertrophy, D-Allose treatment via drinking water notably reduced ISO-induced cardiac hypertrophy and remodelling markers, with minimal effects on ventricular wall thickness observed in echocardiographic analyses. These findings indicate that D-Allose has the ability to attenuate the progression of cardiomyocyte hypertrophy by decreasing intracellular glucose flux and inhibiting glycolysis.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 142-148"},"PeriodicalIF":3.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000586/pdfft?md5=01718de9705446a18a3cda333ebff15e&pid=1-s2.0-S1347861324000586-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Benproperine reduces IL-6 levels via Akt signaling in monocyte/macrophage-lineage cells and reduces the mortality of mouse sepsis model induced by lipopolysaccharide","authors":"Ayumi Kawamura,&nbsp;Akane Ito,&nbsp;Ayaka Takahashi,&nbsp;Atsushi Sawamoto,&nbsp;Satoshi Okuyama,&nbsp;Mitsunari Nakajima","doi":"10.1016/j.jphs.2024.08.001","DOIUrl":"10.1016/j.jphs.2024.08.001","url":null,"abstract":"<div><p>Benproperine (BNP) is a nonnarcotic antitussive drug that is used to treat bronchitis. In the present study, we examined the anti-inflammatory effects of BNP <em>in vitro</em> and <em>in vivo</em>. BNP was found to reduce the secretion of pro-inflammatory cytokines, such as interleukin (IL)-6, in lipopolysaccharide (LPS)-treated RAW264.7 monocyte/macrophage-lineage cells <em>in vitro</em>. As IL-6 is a biomarker for sepsis and has been suggested to exacerbate symptoms, we used an animal model to determine whether BNP reduces IL-6 levels <em>in vivo</em> and improves sepsis symptoms. Notably, BNP reduced IL-6 levels in the lungs of LPS-treated mice and improved LPS-induced hypothermia, one of the symptoms of sepsis. BNP reduced the mortality of septic mice administered a lethal dose of LPS. To reveal the mechanisms underlying the anti-inflammatory function of BNP, we assessed intracellular signaling in LPS-treated RAW264.7 cells. BNP induced the phosphorylation of protein kinase B (Akt) in RAW264.7 cells with/without LPS treatment. Wortmannin, an inhibitor of phosphoinositide 3-kinase reduced the phosphorylation levels of Akt. Wortmannin also obstructed the reduction of IL-6 secretion caused by BNP. Altogether, BNP was found to exhibit an anti-inflammatory function via Akt signaling. Therefore, BNP could be a drug candidate for inflammatory diseases, including sepsis.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 125-133"},"PeriodicalIF":3.0,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000574/pdfft?md5=3c27f63ec96a7dd694bab1cfe047e3f1&pid=1-s2.0-S1347861324000574-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141944361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"β-Adrenoceptor blockade can augment the torsadogenic action of risperidone","authors":"Ai Goto,&nbsp;Ryuichi Kambayashi,&nbsp;Hiroko Izumi-Nakaseko,&nbsp;Yoshinori Takei,&nbsp;Atsushi Sugiyama","doi":"10.1016/j.jphs.2024.07.011","DOIUrl":"10.1016/j.jphs.2024.07.011","url":null,"abstract":"<div><p>Risperidone is a second-generation antipsychotic for treating schizophrenia and bipolar disorder. It can potently inhibit I_Kr, but is classified into conditional risk for torsade de pointes (TdP) by CredibleMeds®. Our previous studies using chronic atrioventricular block dogs showed that risperidone alone did not induce TdP, and that <em>dl</em>-sotalol (β-adrenoceptor blockade plus I_Kr inhibition) induced TdP three times more frequently than <em>d</em>-sotalol (I_Kr inhibition alone). Since risperidone can block α₁-adrenoceptor and decrease blood pressure, the resulting reflex-mediated increase of sympathetic tone on β-adrenoceptor might protect the heart from its I_Kr inhibition-associated TdP. To validate this hypothesis, risperidone was administered to chronic atrioventricular block dogs after β-adrenoceptor blocker atenolol infusion with monitoring J-T_peak and T_peak-T_end, which are proarrhythmic surrogate markers of \"substrate\" and \"trigger\" toward TdP, respectively. Atenolol alone induced TdP in 1 out of 5 dogs; moreover, an additional infusion of risperidone induced TdP in 3 out of 4 dogs. Risperidone prolonged QT interval, J-T_peak and T_peak-T_end in animals that induced TdP. These findings indicate that β-adrenoceptor blockade can diminish repolarization reserve to augment risperidone’s torsadogenic potential, thus advising caution when using β-adrenoceptor blockers in patients with I_Kr inhibition-linked labile repolarization.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 134-141"},"PeriodicalIF":3.0,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000562/pdfft?md5=6a6c58e055f64890f94f471ec0a9accb&pid=1-s2.0-S1347861324000562-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neohesperidin exerts antidepressant-like effect via the mechanistic target of rapamycin complex 1 in the medial prefrontal cortex in male mice","authors":"Satoshi Deyama,&nbsp;Shun Aoki,&nbsp;Rinako Sugie,&nbsp;Katsuyuki Kaneda","doi":"10.1016/j.jphs.2024.07.010","DOIUrl":"10.1016/j.jphs.2024.07.010","url":null,"abstract":"<div><p>Neohesperidin, a citrus flavonoid, shows potential for activating the mechanistic target of rapamycin complex 1 (mTORC1). Here, the antidepressant-like effect of neohesperidin was examined in male ICR mice (naïve mice and mice treated repeatedly with prednisolone, a synthetic glucocorticoid, which induces depression-like behavior). Oral neohesperidin administration exerted an antidepressant-like effect in the forced swim test 1 h post-treatment, in naïve mice; this effect was no longer observed at 24 h. Neohesperidin also reversed prednisolone-induced depression-like behavior. This effect was blocked by infusing rapamycin, an mTORC1 inhibitor, into the medial prefrontal cortex. Neohesperidin may rapidly produce an antidepressant-like effect.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 82-85"},"PeriodicalIF":3.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000550/pdfft?md5=e3920db2afd0c414595dc68e6f9a3abc&pid=1-s2.0-S1347861324000550-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141885295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opposite regulation by L-DOPA receptor GPR143 of the long and short forms of the dopamine D2 receptors","authors":"Rei Tajika ,&nbsp;Daiki Masukawa ,&nbsp;Masami Arai ,&nbsp;Hiroyuki Nawa ,&nbsp;Yoshio Goshima","doi":"10.1016/j.jphs.2024.07.009","DOIUrl":"10.1016/j.jphs.2024.07.009","url":null,"abstract":"<div><p>Dopamine (DA) D2 receptors (D2Rs) have 2 isoforms, a long form (D2L) and a short form (D2S). D2L is predominantly postsynaptic in the striatal medium spiny neurons and cholinergic interneurons. D2S is principally presynaptic autoreceptors in the nigrostriatal DA neurons. Recently, we demonstrated that L-3,4-dihydroxyphenylalanine (L-DOPA) augments D2L function through the coupling between D2L and GPR143, a receptor of L-DOPA that was originally identified as the gene product of ocular albinism 1. Here we show that GPR143 modifies the functions of D2L and D2S in an opposite manner. Haloperidol-induced catalepsy was attenuated in DA neuron-specific <em>Gpr143 gene</em>-deficient (<em>Dat-cre;Gpr143</em>^{<em>flox/y</em>}) mice, compared with wild-type (<em>Wt</em>) mice. Haloperidol increased in vivo DA release from the dorsolateral striatum, and this increase was augmented in <em>Gpr143</em>^<em>-/y</em> mice compared with <em>Wt</em> mice. A D2R agonist quinpirole-induced increase in the phosphorylation of GSK3β(pGSK3β(S9)) was enhanced in Chinese hamster ovary (CHO) cells coexpressing D2L and GPR143 compared with cells expressing D2L alone, while it was suppressed in cells coexpressing D2S and GPR143 compared with D2S alone, suggesting that GPR143 differentially modifies D2R functions depending on its isoforms of D2L and D2S.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 77-81"},"PeriodicalIF":3.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000549/pdfft?md5=0fada20c7d5bb425a552b2ffd56ab094&pid=1-s2.0-S1347861324000549-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141885296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Galantamine suppresses α-synuclein aggregation by inducing autophagy via the activation of α7 nicotinic acetylcholine receptors","authors":"Sora Nozaki ,&nbsp;Masanori Hijioka ,&nbsp;Xiaopeng Wen ,&nbsp;Natsumi Iwashita ,&nbsp;Junya Namba ,&nbsp;Yoshiaki Nomura ,&nbsp;Aoi Nakanishi ,&nbsp;Soichiro Kitazawa ,&nbsp;Ryo Honda ,&nbsp;Yuji O. Kamatari ,&nbsp;Ryo Kitahara ,&nbsp;Kenji Suzuki ,&nbsp;Masatoshi Inden ,&nbsp;Yoshihisa Kitamura","doi":"10.1016/j.jphs.2024.07.008","DOIUrl":"10.1016/j.jphs.2024.07.008","url":null,"abstract":"<div><p>Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are neurodegenerative disorders characterized by the aberrant accumulation of α-synuclein (α-syn). Although no treatment is effective for synucleinopathies, the suppression of α-syn aggregation may contribute to the development of numerous novel therapeutic targets. Recent research revealed that nicotinic acetylcholine (nACh) receptor activation has neuroprotective effects and promotes the degradation of amyloid protein by activating autophagy. In an <em>in vitro</em> human-derived cell line model, we demonstrated that galantamine, the nAChR allosteric potentiating ligand, significantly reduced the cell number of SH-SY5Y cells with intracellular Lewy body-like aggregates by enhancing the sensitivity of α₇-nAChR. In addition, galantamine promoted autophagic flux, and prevented the formation of Lewy body-resembled aggregates. In an <em>in vivo</em> synucleinopathy mouse model, the propagation of α-syn aggregation in the cerebral cortex was inhibited by galantamine administration for 90 days. These results suggest that α₇-nAChR is expected to be a novel therapeutic target, and galantamine is a potential agent for synucleinopathies.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 102-114"},"PeriodicalIF":3.0,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000537/pdfft?md5=aa744b27678a643ecef9a42546b74b7a&pid=1-s2.0-S1347861324000537-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141885299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glucocorticoid-induced acute diuresis in rats in relation to the reduced renal expression of sodium-dependent cotransporter genes","authors":"Peiyan Zhao ,&nbsp;Yoshiki Higashijima ,&nbsp;Hiroko Sonoda ,&nbsp;Rio Morinaga ,&nbsp;Keito Uema ,&nbsp;Akane Oguchi ,&nbsp;Toshiyuki Matsuzaki ,&nbsp;Masahiro Ikeda","doi":"10.1016/j.jphs.2024.07.005","DOIUrl":"10.1016/j.jphs.2024.07.005","url":null,"abstract":"<div><p>Although several studies have shown that glucocorticoids exert diuretic effects in animals and humans, the underlying mechanism responsible for the acute diuretic effect remains obscure. Here we examined the mechanism in terms of gene-expression. We observed that glucocorticoids, including dexamethasone (Dex) and prednisolone (PSL), acutely induced diuresis in rats in a dose-dependent manner. Free water clearance values were negative after Dex or PSL treatment, similar to those observed after treatment with osmotic diuretics (furosemide and acetazolamide). Dex significantly increased the urinary excretion of sodium, potassium, chloride, glucose, and inorganic phosphorus. Renal microarray analysis revealed that Dex significantly altered the renal expression of genes related to transmembrane transport activity. The mRNA levels of sodium/phosphate (<em>NaPi-2a</em>/<em>Slc34a1</em>, <em>NaPi-2b/Slc34a2</em>, and <em>NaPi-2c</em>/<em>Slc34a3</em>) and sodium/glucose cotransporters (<em>Sglt2</em>/<em>Slc5a2</em>) were significantly reduced in the Dex-treated kidney, being negatively correlated with the urinary excretion of their corresponding solutes. Dex did not affect renal expression of the natriuretic peptide receptor 1 (<em>Npr1</em>) gene, or the expression, localization, and phosphorylation of aquaporin-2 (AQP2), a water channel protein. These findings suggest that the acute diuretic effects of glucocorticoids might be mediated by reduced expression of sodium-dependent cotransporter genes.</p></div>","PeriodicalId":16786,"journal":{"name":"Journal of pharmacological sciences","volume":"156 2","pages":"Pages 115-124"},"PeriodicalIF":3.0,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1347861324000501/pdfft?md5=24cc0b983274fa57852681e87efd3633&pid=1-s2.0-S1347861324000501-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141844691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}